Efficacy and Safety of Memantine for Parkinson's Disease Dementia (PDD) and Dementia With Lewy Bodies (DLB)
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
A 24-week placebo-controlled parallel group multicentre trial to study the safety and
efficacy of memantine in patients with dementia associated with Parkinson's disease and
dementia with Lewy bodies. It is hypothesized that memantine will be safe and well tolerated,
and more effective than placebo.